首页|动态增强MRI联合血清SPINK1水平诊断原发性肝癌价值研究

动态增强MRI联合血清SPINK1水平诊断原发性肝癌价值研究

扫码查看
目的 探讨动态增强磁共振(MRI)联合血清丝氨酸蛋白酶抑制剂因子Kazal 1型(SPTINK1)水平诊断原发性肝癌(PLC)的价值。方法 2020年4月~2023年4月我院收治的乙型肝炎肝硬化患者204例,均接受动态增强MRI扫描检查,对肝内占位性病变者行细针穿刺病理学检查。采用ELISA法检测血清SPTINK1和甲胎蛋白水平。应用二元多因素Logistic回归分析诊断HCC的血清指标,应用受试者工作特征曲线(ROC)分析血清指标的诊断效能。结果 在204例乙型肝炎肝硬化患者中,发现肝内占位性病变并经穿刺病理学检查诊断肝细胞癌(HCC)30例(14。7%);HCC组血清SPTINK1和AFP水平分别为(23。9±5。2)ng/mL和(426。5±67。0)ng/mL,显著高于肝硬化组[分别为(7。4±2。1)ng/mL和(14。4±4。3)ng/mL,P<0。05];血清 SPTINK1(OR:3。69,95%CI:1。08~12。49)和甲胎蛋白(AFP,OR:3。54,95%CI:1。04~11。98)均与HCC高度相关;以血清AFP水平大于等于360。1 ng/mL为截断点,其诊断HCC的AUC为0。80(95%CI:0。72~0。89),灵敏度和特异度分别为71%和73%,以血清SPTINK1水平等于或大于15。6 ng/mL为截断点,其诊断HCC的AUC为0。82(95%CI:0。74~0。91),灵敏度和特异度分别为82%和79%。结论 在肝硬化患者,经影像学检查发现肝内占位性病变时,血清SPINK1和AFP水平升高可以帮助初步判断病变性质,应尽早进行穿刺病理学检查。
Diagnostic performance of serum SPINK1 levels for hepatocellular carcinoma in patients with hepatitis B-induced liver cirrhosis
Objective The purpose of this study was to investigate the diagnostic performance of serum serine protease inhibitor Kazal type 1(SPINK1)levels for hepatocellular carcinoma(HCC)in patients with hepatitis B-induced liver cirrhosis(LC).Methods A total of 204 consecutive patients with hepatitis B-induced LC were encountered in our hospital between April 2020 and April 2023,andall underwent dynamic contrast-enhanced magnetic resonance imaging(MRI).The patients who had intrahepatic space-occupying lesions received fine needle aspiration biopsies(FNAB)for histo-pathological examination.Serum SPTINK1 and alpha-fetoprotein(AFP)levels were detected by ELISA.The multivariate Logistic regression analysis and receiver-operating characteristic curve(ROC)were applied to predict the diagnostic efficacy.Results Out the 204 patients with hepatitis B-induced LC,the intrahepatic space-occupying lesions were found in 30 cases(14.7%)by MRI,and the histo-pathological examination showed all with HCC;serum SPTINK1 and AFP levels in patients with HCC were(23.9±5.2)ng/mL and(426.5± 67.0)ng/mL,both significantly higher than[(7.4±2.1)ng/mL and(14.4±4.3)ng/mL,respectively,P<0.05]in those with LC;both serum SPTINK1(OR:3.69,95%CI:1.08-12.49)and AFP(OR:3.54,95%CI:1.04-11.98)were positively correlated to HCC existence;the AUC was 0.80(95%CI:0.72-0.89),with the sensitivity(Se)of 71%and the specificity(Sp)of 73%,when serum AFP level equal to or greater than 360.1 ng/mL was set as the cut-off-value,and the AUC was 0.82(95%CI:0.74-0.91),with the Se of 82%and the Sp of 79%,when serum SPTINK1 level equal to or greater than 15.6 ng/mL was set as the cut-off-value in diagnosing HCC.Conclusion The elevated serum SPINK1 and AFP levels might hint the malignant tumor in LC patients with MRI-proven space-occupying lesions,and the FNAB could determine the diagnosis.

HepatomaLiver cirrhosisEnhanced magnetic resonanceProtease inhibitor Kazal type 1Alpha-fetoproteinDiagnosis

王倩文、胡琳琳、徐运军

展开 >

230000 合肥市 中国科学技术大学附属第一医院影像科

新疆生产建设兵团第十师北屯医院放射科

肝细胞癌 肝硬化 增强磁共振成像 丝氨酸蛋白酶抑制剂因子Kazal 1型 甲胎蛋白 诊断

安徽省自然科学基金资助项目

2208085MH259

2024

实用肝脏病杂志
中华医学会安徽分会

实用肝脏病杂志

CSTPCD
影响因子:1.362
ISSN:1672-5069
年,卷(期):2024.27(3)
  • 25